Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination treatment of SGLT2 inhibitors and dopamine agonists for preventing metabolic disorders in equine animals

Combination treatment of SGLT2 inhibitors and dopamine agonists for preventing metabolic disorders in equine animals

US Patent 10555958 · Granted Feb 11, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of SGLT-2 inhibitors in the drying-off of non-human mammals2025
Treatment of metabolic disorders in feline animals2024
Use of SGLT-2 inhibitors in the drying-off of non-human mammals2023
Treatment of metabolic disorders in canine animals2022
Modular antigen transportation molecules and uses therof2021
Modular antigen transportation molecules and uses thereof in animals2021
Treatment of metabolic disorders in equine animals2020
Treatment of metabolic disorders in equine animals2020
Treatment of metabolic disorders in feline animals2020
Treatment of metabolic disorders in canine animals2020
Device and system for delivery of an aerosol to a patient on ventilatory support2019
Modular antigen transportation molecules and uses therof2018